ClinicalTrials.gov
ClinicalTrials.gov Menu

An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Follicular Lymphoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01609036
Recruitment Status : Terminated
First Posted : May 31, 2012
Last Update Posted : November 2, 2016
Sponsor:
Information provided by (Responsible Party):
Hoffmann-La Roche

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Terminated
  Actual Primary Completion Date : November 2012
  Actual Study Completion Date : November 2012